Biomarker enhanced risk prediction for development of AKI after cardiac surgery
BMC Nephrology May 09, 2018
Merchant ML, et al. - Experts intended to identify preoperative candidate urine biomarkers in patients undergoing cardiac surgery. The researchers concluded that pre-operative urine measurement of complement factor B (CFB) or histidine rich glycoprotein (HRG) significantly enhanced the current post-surgery acute kidney injury (AKI) risk stratification for a more restrictive definition of AKI. Findings revealed that HRG, but not CFB or clinical risk stratification, predicted AKI defined by Kidney Disease Improving Global Outcomes (KDIGO), however, the ability of these biomarkers to predict risk for dialysis-requiring AKI or death could not be reliably evaluated due to a small number of patients with either outcome.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries